Literature DB >> 9349044

The psychosocial impact of urinary incontinence on women aged 25 to 45 years.

A J Valerius1.   

Abstract

The purpose of this research was to describe the relationship between symptoms of urinary incontinence and their impact on daily activities, and the degree of incontinence-related distress perceived by 25- to 45-year-old women. A second purpose was to identify differences, if any, in impact on daily life and degree of incontinence-related distress perceived among women with stress, urge, and mixed incontinence. Guided by Lazarus and Folkman's (1984) Stress, Appraisal and Coping Theory, a descriptive correlational prospective study (N = 35) was conducted using the Urogenital Distress Inventory and the Incontinence Impact Questionnaire. A significant moderate (r = 0.5701, p = 0.000) correlation was found between urinary incontinence symptoms and their impact on travel, social, physical, and emotional activities. No significant differences were found among women with stress, urge, and mixed urinary incontinence and the impact of incontinence symptoms on their daily activities or with their perceived degree of incontinence-related distress.

Entities:  

Mesh:

Year:  1997        PMID: 9349044

Source DB:  PubMed          Journal:  Urol Nurs        ISSN: 1053-816X


  3 in total

1.  The effect of vaginal and cesarean delivery on lower urinary tract symptoms: what makes the difference?

Authors:  Henriette Jorien van Brummen; Hein W Bruinse; Geerte van de Pol; A Peter M Heintz; C Huub van der Vaart
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-04-21

2.  Urinary incontinence in women under 65: quality of life, stress related to incontinence and patterns of seeking health care.

Authors:  Ilana Margalith; Gabriel Gillon; David Gordon
Journal:  Qual Life Res       Date:  2004-10       Impact factor: 4.147

3.  Needs assessment of women with urinary incontinence in a district health authority.

Authors:  K MacKay; L Hemmett
Journal:  Br J Gen Pract       Date:  2001-10       Impact factor: 5.386

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.